Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

744 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires.
Costedoat-Chalumeau N, Houssiau F, Izmirly P, Guern VL, Navarra S, Jolly M, Ruiz-Irastorza G, Baron G, Hachulla E, Agmon-Levin N, Shoenfeld Y, Dall'Ara F, Buyon J, Deligny C, Cervera R, Lazaro E, Bezanahary H, Leroux G, Morel N, Viallard JF, Pineau C, Galicier L, Vollenhoven RV, Tincani A, Nguyen H, Gondran G, Zahr N, Pouchot J, Piette JC, Petri M, Isenberg D. Costedoat-Chalumeau N, et al. Among authors: cervera r. Clin Pharmacol Ther. 2019 Aug;106(2):374-382. doi: 10.1002/cpt.1194. Epub 2018 Sep 2. Clin Pharmacol Ther. 2019. PMID: 30079582
Association of 16/6 and SA1 anti-DNA idiotypes with anticardiolipin antibodies and clinical manifestations in a large cohort of SLE patients. European Concerted Action on the Immunogenetics of SLE.
Galeazzi M, Bellisai F, Sebastiani GD, Morozzi G, Marcolongo R, Houssiau F, Cervera R, Levy Y, George J, Sherer Y, Shoenfeld Y. Galeazzi M, et al. Among authors: cervera r. Clin Exp Rheumatol. 1998 Nov-Dec;16(6):717-20. Clin Exp Rheumatol. 1998. PMID: 9844765 Clinical Trial.
Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus.
Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Aydintug AO, Jedryka-Góral A, de Ramón E, Fernández-Nebro A, Galeazzi M, Haga HJ, Mathieu A, Houssiau F, Ruiz-Irastorza G, Ingelmo M, Hughes GR. Cervera R, et al. Medicine (Baltimore). 1999 May;78(3):167-75. doi: 10.1097/00005792-199905000-00003. Medicine (Baltimore). 1999. PMID: 10352648 Free article.
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.
Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, Jacobsen S, Lakos G, Tincani A, Kontopoulou-Griva I, Galeazzi M, Meroni PL, Derksen RH, de Groot PG, Gromnica-Ihle E, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quéré I, Hachulla E, Vasconcelos C, Roch B, Fernández-Nebro A, Boffa MC, Hughes GR, Ingelmo M; Euro-Phospholipid Project Group. Cervera R, et al. Arthritis Rheum. 2002 Apr;46(4):1019-27. doi: 10.1002/art.10187. Arthritis Rheum. 2002. PMID: 11953980 Free article.
Antiphospholipid syndrome: pathogenic mechanisms.
Espinosa G, Cervera R, Font J, Shoenfeld Y. Espinosa G, et al. Among authors: cervera r. Autoimmun Rev. 2003 Mar;2(2):86-93. doi: 10.1016/s1568-9972(02)00144-1. Autoimmun Rev. 2003. PMID: 12848964 Review.
Prevalence and clinical correlations of antibodies against six beta2-glycoprotein-I-related peptides in the antiphospholipid syndrome.
Shoenfeld Y, Krause I, Kvapil F, Sulkes J, Lev S, von Landenberg P, Font J, Zaech J, Cervera R, Piette JC, Boffa MC, Khamashta MA, Bertolaccini ML, Hughes GR, Youinou P, Meroni PL, Pengo V, Alves JD, Tincani A, Szegedi G, Lakos G, Sturfelt G, Jönsen A, Koike T, Sanmarco M, Ruffatti A, Ulcova-Gallova Z, Praprotnik S, Rozman B, Lorber M, Vriezman VB, Blank M. Shoenfeld Y, et al. Among authors: cervera r. J Clin Immunol. 2003 Sep;23(5):377-83. doi: 10.1023/a:1025321617304. J Clin Immunol. 2003. PMID: 14601646
Antiphospholipid syndrome infectious origin.
Blank M, Asherson RA, Cervera R, Shoenfeld Y. Blank M, et al. Among authors: cervera r. J Clin Immunol. 2004 Jan;24(1):12-23. doi: 10.1023/B:JOCI.0000018058.28764.ce. J Clin Immunol. 2004. PMID: 14997029 Review.
Features associated with epilepsy in the antiphospholipid syndrome.
Shoenfeld Y, Lev S, Blatt I, Blank M, Font J, von Landenberg P, Lev N, Zaech J, Cervera R, Piette JC, Khamashta MA, Bertolaccini ML, Hughes GR, Youinou P, Meroni PL, Pengo V, Alves JD, Tincani A, Szegedi G, Lakos G, Sturfelt G, Jönsen A, Koike T, Sanmarco M, Ruffatti A, Ulcova-Gallova Z, Praprotnik S, Rozman B, Lorber M, Chapman J, van-Breda-Vriezman PJ, Damoiseaux J. Shoenfeld Y, et al. Among authors: cervera r. J Rheumatol. 2004 Jul;31(7):1344-8. J Rheumatol. 2004. PMID: 15229954
744 results